Experts tie chemotherapy to slight increase in AML risk

02/14/2013 | HealthDay News

Patients who underwent chemotherapy for non-Hodgkin lymphoma and esophageal, prostate and cervical cancers faced an increased risk of developing acute myeloid leukemia, according to a new study. However, treatment was associated with lower AML risk in patients who had ovarian cancer, myeloma, and possibly lung cancer, researchers said. The findings appear in the journal Blood.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL